196 related articles for article (PubMed ID: 21715332)
21. Cleavage of arrestin-3 by caspases attenuates cell death by precluding arrestin-dependent JNK activation.
Kook S; Vishnivetskiy SA; Gurevich VV; Gurevich EV
Cell Signal; 2019 Feb; 54():161-169. PubMed ID: 30529266
[TBL] [Abstract][Full Text] [Related]
22. beta-Arrestins facilitate ubiquitin-dependent degradation of apoptosis signal-regulating kinase 1 (ASK1) and attenuate H2O2-induced apoptosis.
Zhang Z; Hao J; Zhao Z; Ben P; Fang F; Shi L; Gao Y; Liu J; Wen C; Luo L; Yin Z
Cell Signal; 2009 Jul; 21(7):1195-206. PubMed ID: 19306926
[TBL] [Abstract][Full Text] [Related]
23. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
[TBL] [Abstract][Full Text] [Related]
24. The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation.
Coffa S; Breitman M; Hanson SM; Callaway K; Kook S; Dalby KN; Gurevich VV
PLoS One; 2011; 6(12):e28723. PubMed ID: 22174878
[TBL] [Abstract][Full Text] [Related]
25. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
26. GPCR binding and JNK3 activation by arrestin-3 have different structural requirements.
Zheng C; Weinstein LD; Nguyen KK; Grewal A; Gurevich EV; Gurevich VV
bioRxiv; 2023 May; ():. PubMed ID: 37205393
[TBL] [Abstract][Full Text] [Related]
27. Beta-arrestin mediates desensitization and internalization but does not affect dephosphorylation of the thyrotropin-releasing hormone receptor.
Jones BW; Hinkle PM
J Biol Chem; 2005 Nov; 280(46):38346-54. PubMed ID: 16183993
[TBL] [Abstract][Full Text] [Related]
28. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5.
Bolger GB; Baillie GS; Li X; Lynch MJ; Herzyk P; Mohamed A; Mitchell LH; McCahill A; Hundsrucker C; Klussmann E; Adams DR; Houslay MD
Biochem J; 2006 Aug; 398(1):23-36. PubMed ID: 16689683
[TBL] [Abstract][Full Text] [Related]
29. Arrestin-3-Dependent Activation of c-Jun N-Terminal Kinases (JNKs).
Zhan X; Kaoud TS; Dalby KN; Gurevich EV; Gurevich VV
Curr Protoc; 2023 Sep; 3(9):e839. PubMed ID: 37668419
[TBL] [Abstract][Full Text] [Related]
30. The neuroprotective effect of losartan through inhibiting AT1/ASK1/MKK4/JNK3 pathway following cerebral I/R in rat hippocampal CA1 region.
Zhang TL; Fu JL; Geng Z; Yang JJ; Sun XJ
CNS Neurosci Ther; 2012 Dec; 18(12):981-7. PubMed ID: 23095236
[TBL] [Abstract][Full Text] [Related]
31. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation.
Kara E; Crépieux P; Gauthier C; Martinat N; Piketty V; Guillou F; Reiter E
Mol Endocrinol; 2006 Nov; 20(11):3014-26. PubMed ID: 16887887
[TBL] [Abstract][Full Text] [Related]
32. G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR.
Miller WE; Houtz DA; Nelson CD; Kolattukudy PE; Lefkowitz RJ
J Biol Chem; 2003 Jun; 278(24):21663-71. PubMed ID: 12668664
[TBL] [Abstract][Full Text] [Related]
33. Visual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm.
Song X; Raman D; Gurevich EV; Vishnivetskiy SA; Gurevich VV
J Biol Chem; 2006 Jul; 281(30):21491-21499. PubMed ID: 16737965
[TBL] [Abstract][Full Text] [Related]
34. Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation.
McLaughlin NJ; Banerjee A; Kelher MR; Gamboni-Robertson F; Hamiel C; Sheppard FR; Moore EE; Silliman CC
J Immunol; 2006 Jun; 176(11):7039-50. PubMed ID: 16709866
[TBL] [Abstract][Full Text] [Related]
35. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Barnes WG; Lefkowitz RJ
J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
[TBL] [Abstract][Full Text] [Related]
36. Structural basis of arrestin-3 activation and signaling.
Chen Q; Perry NA; Vishnivetskiy SA; Berndt S; Gilbert NC; Zhuo Y; Singh PK; Tholen J; Ohi MD; Gurevich EV; Brautigam CA; Klug CS; Gurevich VV; Iverson TM
Nat Commun; 2017 Nov; 8(1):1427. PubMed ID: 29127291
[TBL] [Abstract][Full Text] [Related]
37. Differential conformational requirements for activation of G proteins and the regulatory proteins arrestin and G protein-coupled receptor kinase in the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein.
Vilardaga JP; Frank M; Krasel C; Dees C; Nissenson RA; Lohse MJ
J Biol Chem; 2001 Sep; 276(36):33435-43. PubMed ID: 11387315
[TBL] [Abstract][Full Text] [Related]
38. Mapping the arrestin-receptor interface. Structural elements responsible for receptor specificity of arrestin proteins.
Vishnivetskiy SA; Hosey MM; Benovic JL; Gurevich VV
J Biol Chem; 2004 Jan; 279(2):1262-8. PubMed ID: 14530255
[TBL] [Abstract][Full Text] [Related]
39. Paired activation of two components within muscarinic M3 receptor dimers is required for recruitment of beta-arrestin-1 to the plasma membrane.
Novi F; Stanasila L; Giorgi F; Corsini GU; Cotecchia S; Maggio R
J Biol Chem; 2005 May; 280(20):19768-76. PubMed ID: 15769745
[TBL] [Abstract][Full Text] [Related]
40. K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways.
Pan J; Wang G; Yang HQ; Hong Z; Xiao Q; Ren RJ; Zhou HY; Bai L; Chen SD
Mol Pharmacol; 2007 Dec; 72(6):1607-18. PubMed ID: 17855652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
